decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Appendix E - National Coverage Determinations Manual / PROSTATE_SPECIFIC_ANTIGEN
Subscribe or sign in to view the full article.
Article Overview
This page presents National Coverage Determinations Manual guidance for prostate-specific antigen (PSA) testing. It explains the general clinical contexts in which PSA testing is discussed, the types of patient presentations addressed, and the main coverage limitations tied to how often the test may be performed. The article is relevant to coders, billers, and compliance staff working with prostate cancer-related laboratory services and Medicare coverage policy.
Why This Topic Matters
PSA testing is commonly used in prostate cancer evaluation and follow-up, so understanding the coverage framework helps support compliant ordering, billing, and medical necessity review for Medicare claims.
What You Will Learn
- The clinical contexts addressed by Medicare coverage guidance for PSA testing
- The general patient scenarios discussed in relation to PSA use
- The scope of frequency limitations described in the policy
- How the article frames PSA in diagnostic and follow-up settings
Who Should Read This
- Medical coders
- Medical billers
- Compliance staff
- Revenue cycle teams
- Clinicians involved in prostate cancer testing
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com